Cue Biopharma amends SVB credit agreement, eliminates $20M cash reserve requirement

Cue Biopharma, Inc.

Second Amendment dated Oct 2, 2024 removes $20M minimum cash requirement from SVB loan agreement.
New covenant requires Cue to maintain at SVB lesser of $20M or 100% of consolidated cash.
No Event of Default occurred; representations and warranties reaffirmed as of effective date.
All other terms of the Loan and Security Agreement remain unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.